BG64283B1 - ПРОИЗВОДНИ НА 4-ОК'О-3,5-ДИХИДРО-4Н-ПИРИДАЗИНО[4,5-b] ИНДОЛ-1-А-...'АМИД, 'ЯХНО'О ПОЛ"-АВАН... И ИЗПОЛЗВАН...'О ИМ В '...РАПИЯ'А - Google Patents

ПРОИЗВОДНИ НА 4-ОК'О-3,5-ДИХИДРО-4Н-ПИРИДАЗИНО[4,5-b] ИНДОЛ-1-А-...'АМИД, 'ЯХНО'О ПОЛ"-АВАН... И ИЗПОЛЗВАН...'О ИМ В '...РАПИЯ'А Download PDF

Info

Publication number
BG64283B1
BG64283B1 BG104096A BG10409600A BG64283B1 BG 64283 B1 BG64283 B1 BG 64283B1 BG 104096 A BG104096 A BG 104096A BG 10409600 A BG10409600 A BG 10409600A BG 64283 B1 BG64283 B1 BG 64283B1
Authority
BG
Bulgaria
Prior art keywords
mmol
dihydro
pyridazino
methyl
indole
Prior art date
Application number
BG104096A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG104096A (en
Inventor
Yannick Evanno
Laurent Dubois
Mireille Sevrin
Frank Marguet
Jacques Froissant
Regine Bartsch
Catherine Gille
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of BG104096A publication Critical patent/BG104096A/xx
Publication of BG64283B1 publication Critical patent/BG64283B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG104096A 1997-07-30 2000-01-20 ПРОИЗВОДНИ НА 4-ОК'О-3,5-ДИХИДРО-4Н-ПИРИДАЗИНО[4,5-b] ИНДОЛ-1-А-...'АМИД, 'ЯХНО'О ПОЛ"-АВАН... И ИЗПОЛЗВАН...'О ИМ В '...РАПИЯ'А BG64283B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709692A FR2766823B1 (fr) 1997-07-30 1997-07-30 Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
PCT/FR1998/001667 WO1999006406A1 (fr) 1997-07-30 1998-07-28 DERIVES DE 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b] INDOLE-1-ACETAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (2)

Publication Number Publication Date
BG104096A BG104096A (en) 2000-08-31
BG64283B1 true BG64283B1 (bg) 2004-08-31

Family

ID=9509801

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104096A BG64283B1 (bg) 1997-07-30 2000-01-20 ПРОИЗВОДНИ НА 4-ОК'О-3,5-ДИХИДРО-4Н-ПИРИДАЗИНО[4,5-b] ИНДОЛ-1-А-...'АМИД, 'ЯХНО'О ПОЛ"-АВАН... И ИЗПОЛЗВАН...'О ИМ В '...РАПИЯ'А

Country Status (32)

Country Link
US (1) US6262045B1 (cs)
EP (1) EP1000063B1 (cs)
JP (1) JP4322421B2 (cs)
KR (1) KR100497782B1 (cs)
CN (1) CN1134440C (cs)
AR (1) AR013264A1 (cs)
AT (1) ATE226584T1 (cs)
AU (1) AU736600B2 (cs)
BG (1) BG64283B1 (cs)
BR (1) BR9811582B1 (cs)
CA (1) CA2298522C (cs)
CO (1) CO5210883A1 (cs)
CZ (1) CZ290011B6 (cs)
DE (1) DE69808921T2 (cs)
DK (1) DK1000063T3 (cs)
EE (1) EE04317B1 (cs)
ES (1) ES2186212T3 (cs)
FR (1) FR2766823B1 (cs)
HU (1) HU229430B1 (cs)
IL (1) IL133633A (cs)
NO (1) NO313963B1 (cs)
NZ (1) NZ502361A (cs)
PL (1) PL194245B1 (cs)
PT (1) PT1000063E (cs)
RU (1) RU2197490C2 (cs)
SI (1) SI1000063T1 (cs)
SK (1) SK283075B6 (cs)
TR (1) TR200000278T2 (cs)
TW (1) TW506971B (cs)
UA (1) UA57088C2 (cs)
WO (1) WO1999006406A1 (cs)
ZA (1) ZA986786B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
FR2788696B1 (fr) * 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
GB0000564D0 (en) * 2000-01-11 2000-03-01 Merck Sharp & Dohme Therapeutic agents
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2838124B1 (fr) 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
JP4912320B2 (ja) * 2004-12-07 2012-04-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換された四環式テトラヒドロピラン、ピロリジンおよびテトラヒドロチオフェン誘導体
RU2409352C2 (ru) * 2005-05-05 2011-01-20 САНОФИ-АВЕНТИС Ю.Эс. ЭлЭлСи Стабильные составы наночастиц
JP5026426B2 (ja) * 2005-08-29 2012-09-12 サノフイ−アベンテイス・ユー・エス・エルエルシー ７−クロロ−Ｎ，Ｎ，５−トリメチル−４−オキソ−３−フェニル−３，５−ジヒドロ−４Ｈ−ピリダジノ［４，５−ｂ］インドール−１−アセトアミドのアモルファス固体分散体
EP1924585B1 (en) * 2005-08-29 2011-11-02 Sanofi-Aventis U.S. LLC Novel crystalline form of a pyridazino [4 , 5-b] indole derivative
WO2007038209A2 (en) * 2005-09-23 2007-04-05 Schering Corporation Fused tetracyclic mglur1 antagonists as therapeutic agents
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
KR20110052640A (ko) * 2008-08-18 2011-05-18 사노피-아벤티스 유.에스. 엘엘씨 7-클로로-Ｎ,Ｎ,5-트리메틸-4-옥소-3-페닐-3,5-디하이드로-4Ｈ-피리다지노[4,5-ｂ]인돌-1-아세트아미드의 다형체의 제조방법
EP2181717A1 (en) 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985560A (en) * 1990-01-12 1991-01-15 American Home Products Corporation Pyridazino(4,5-b)indolizines
FI94531C (fi) * 1990-03-13 1995-09-25 Ime Intermed Enterpris Sa Menetelmä farmaseuttisesti aktiivisen 1,3,4,6,7,8-heksahydro-2H-pyrimido-(1,2-a)-pyrimidiinijohdannaisen valmistamiseksi
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
US5756501A (en) * 1995-12-13 1998-05-26 American Home Products Corporation Saturated and unsaturated pyridazino 4,5-B! indolizines useful as antidementia agents
FR2754262B1 (fr) 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CO5210883A1 (es) 2002-10-30
WO1999006406A1 (fr) 1999-02-11
ATE226584T1 (de) 2002-11-15
BR9811582B1 (pt) 2010-10-19
TR200000278T2 (tr) 2000-08-21
DE69808921D1 (de) 2002-11-28
HUP0002650A2 (hu) 2001-01-29
DE69808921T2 (de) 2003-07-03
CN1134440C (zh) 2004-01-14
KR100497782B1 (ko) 2005-06-27
BR9811582A (pt) 2000-09-26
IL133633A0 (en) 2001-04-30
SK283075B6 (sk) 2003-02-04
NO20000462D0 (no) 2000-01-28
EP1000063B1 (fr) 2002-10-23
CZ2000320A3 (cs) 2000-05-17
FR2766823B1 (fr) 1999-10-08
ZA986786B (en) 1999-02-02
PL194245B1 (pl) 2007-05-31
IL133633A (en) 2004-02-08
SK1292000A3 (en) 2000-08-14
EE04317B1 (et) 2004-06-15
FR2766823A1 (fr) 1999-02-05
CZ290011B6 (cs) 2002-05-15
HUP0002650A3 (en) 2002-09-30
NZ502361A (en) 2001-06-29
SI1000063T1 (en) 2003-04-30
US6262045B1 (en) 2001-07-17
CA2298522A1 (en) 1999-02-11
CN1265108A (zh) 2000-08-30
TW506971B (en) 2002-10-21
BG104096A (en) 2000-08-31
ES2186212T3 (es) 2003-05-01
AU8983298A (en) 1999-02-22
HK1028027A1 (en) 2001-02-02
AR013264A1 (es) 2000-12-13
AU736600B2 (en) 2001-08-02
HU229430B1 (en) 2013-12-30
CA2298522C (en) 2008-07-15
UA57088C2 (uk) 2003-06-16
EP1000063A1 (fr) 2000-05-17
JP4322421B2 (ja) 2009-09-02
EE200000056A (et) 2000-10-16
DK1000063T3 (da) 2003-02-24
RU2197490C2 (ru) 2003-01-27
PT1000063E (pt) 2003-03-31
KR20010022356A (ko) 2001-03-15
JP2001512122A (ja) 2001-08-21
NO20000462L (no) 2000-03-29
PL338445A1 (en) 2000-11-06
NO313963B1 (no) 2003-01-06

Similar Documents

Publication Publication Date Title
US6262045B1 (en) 4-Oxo-3,5-dihydro-4H-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy
SK285703B6 (sk) 2-Aryl-8-oxodihydropurínový derivát, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahoma medziprodukt na jeho prípravu
US6075021A (en) 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and application thereof in therapeutics
CZ20002691A3 (cs) Triazolopyridazinové deriváty
EA004373B1 (ru) 1-АМИНОТРИАЗОЛО[4,3-a]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ IV
US5512590A (en) 5,6-dihydro-4h-imidazo 2',1':2,3!imidazo- 4,5,1-ij!quinoline and 4,5-dihydroimidazo- 1,2-a!pyrolo 1,2,3-cd!benzimidazole derivatives, their preparation and application in therapeutics
DK167681B1 (da) 3-benzyl-3h-1,2,3-triazolooe4,5-daapyrimidiner i fri form eller i saltform, fremgangsmaade til deres fremstilling, deres anvendelse som laegemiddel og til fremstilling af et farmaceutisk praeparat samt farmaceutisk praeparat og dettes fremstilling
SK4694A3 (en) 9h-imidazo (1,2,-a) benzimidazole-3-acetamide derivatives method of their preparation and pharmaceutical compounds containing these derivatives
US3709899A (en) 6-phenyl-4h-s-triazolo(4,3-a)(1,4)benzodiazepines and their production
EP1150983A1 (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
US4482714A (en) Pyrazino[2',3'-3,4]pyrido[1,2-a]indole derivatives
US4515949A (en) [2-(1H-indol-1-yl)ethyl]-2-piperazine and pyrido[1,2-a]indol-9-one as intermediates for pyrazino(2,3-3,4)pyrido(1,2-a) indoles which are useful for treating hypertension in mammals
IE43762B1 (en) Diazepine derivatives
MXPA00001009A (en) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b
HK1028027B (en) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b)-indole-1-acetamide derivatives, their preparation and their application in therapy